KEAP1 and colorectal cancer: identified a novel ROS/KEAP1/NRF2 pathway through which curcumin modulates the expression of miR‐34a/b/c in colorectal cancer (CRC) cells, subsequently reducing metastatic potential and enhancing apoptosis (Liu et al. 2023).